Figure 1From: Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia Changes in IPSS and QOL score by the treatment with silodosin (n=91). *Mean ± SD. **p<0.01 by Wilcoxon signed-rank test.Back to article page